Marcel Verheij, MD, PhD, on Resectable Gastric Cancer: Comparing Three Preoperative Regimens

January 22, 2026 By The ASCO Post Staff

Marcel Verheij, MD, PhD, of Radboud University Medical Center, presents findings from the phase II CRITICS-II trial, which compared three preoperative regimens while omitting adjuvant treatment among patients with nonmetastatic resectable gastric cancer: chemotherapy, chemotherapy followed by chemoradiotherapy, and chemoradiotherapy (Abstract 283). 

Related Content